hDMT highlighted in Year Review 2018 of Top Sector LSH
In the Year in Review 2018 published by the Top Sector Life Sciences & Health, named Health~Holland, hDMT is highlighted as one of the four strategic public-private partnerships they support during their fundamental, industrial and experimental R&D.
Screenshot Year in Review Health~Holland
[Text below comes from the Year Review]
human organ and Disease Model Technologies (hDMT)
The new European Organ-on-Chip Society (EUROoCS) was officially launched in November 2018. The purpose of the society is to encourage and develop Organ-on-Chip (OoC) research, and to provide opportunities to share and advance knowledge and expertise in this field.
hDMT and Top Sector LSH joined forces in a new call, named Health~Holland Organ-on-Chip Showcases, to stimulate the early phase in OoC technology development. After building a strong national platform and attracting substantial financial funding for R&D, hDMT expanded to a European level last autumn. The EUROoCS is one of the first outcomes of the Horizon 2020 project ORCHID (Organ-on-Chip In Development), which aims to create a roadmap for Organ-on-Chip technology and to build a network of all parties involved.